🇺🇸 FDA
Patent

US 11202789

Method of treating glycogen storage disease

granted A61KA61K31/662A61K31/665

Quick answer

US patent 11202789 (Method of treating glycogen storage disease) held by Viking Therapeutics, Inc. expires Mon Dec 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Viking Therapeutics, Inc.
Grant date
Tue Dec 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/662, A61K31/665, A61K31/683, A61K45/06